Supplementary Table 3 from MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951

MLA

Pim J. French, et al. Supplementary Table 3 from MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7dcc2511ce581d2a725ad4424ba013ec&authtype=sso&custid=ns315887.

APA

Pim J. French, Thierry Gorlia, Johan M. Kros, Peter A.E. Sillevis Smitt, Pieter Wesseling, Cees Tijssen, Wilfred F.A. den Dunnen, Wim G.M. Spliet, Paul H.C. Eilers, Johan de Rooi, Ahmed Idbaih, Lale Erdem-Eraslan, & Martin J. van den Bent. (2023). Supplementary Table 3 from MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951.

Chicago

Pim J. French, Thierry Gorlia, Johan M. Kros, Peter A.E. Sillevis Smitt, Pieter Wesseling, Cees Tijssen, Wilfred F.A. den Dunnen, et al. 2023. “Supplementary Table 3 from MGMT-STP27 Methylation Status as Predictive Marker for Response to PCV in Anaplastic Oligodendrogliomas and Oligoastrocytomas. A Report from EORTC Study 26951,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7dcc2511ce581d2a725ad4424ba013ec&authtype=sso&custid=ns315887.